P

Inventor

BOOKER SHON

US37 patents
⚠️ This page may combine multiple inventors who share the name “BOOKER SHON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

30 patents
US10640504B2May 5, 2020

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC50 citations97
US10532042B2Jan 14, 2020

KRAS G12C inhibitors and methods of using the same

AMGEN INC49 citations97
US10519146B2Dec 31, 2019

KRAS G12C inhibitors and methods of using the same

AMGEN INC81 citations97
US6878714B2Apr 12, 2005

Substituted alkylamine derivatives and methods of use

AMGEN INC85 citations97
US6995162B2Feb 7, 2006

Substituted alkylamine derivatives and methods of use

AMGEN INC48 citations95
US11306087B2Apr 19, 2022

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC16 citations94
US11096939B2Aug 24, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC24 citations94
US11090304B2Aug 17, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC33 citations94
US11285135B2Mar 29, 2022

KRAS G12C inhibitors and methods of using the same

AMGEN INC20 citations93
US7858623B2Dec 28, 2010

Substituted amide derivatives and methods of use

AMGEN INC15 citations93
US7435823B2Oct 14, 2008

Compounds and methods of use

AMGEN INC19 citations92
US7102009B2Sep 5, 2006

Substituted amine derivatives and methods of use

AMGEN INC49 citations92
US9066954B2Jun 30, 2015

Fused heterocyclic derivatives and methods of use

AMGEN INC22 citations91
US7928140B2Apr 19, 2011

Benzothiazole PI3 kinase modulators for cancer treatment

AMGEN INC32 citations91
US7820665B2Oct 26, 2010

Imidazopyridazine inhibitors of PI3 kinase for cancer treatment

AMGEN INC38 citations91
US7652009B2Jan 26, 2010

Substituted heterocycles and methods of use

AMGEN INC33 citations91
US12083121B2Sep 10, 2024

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC7 citations85
US11993597B2May 28, 2024

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC8 citations85
US11905281B2Feb 20, 2024

KRAS G12C inhibitors and methods of using the same

AMGEN INC13 citations85
US11766436B2Sep 26, 2023

KRAS G12C inhibitors and methods of using the same

AMGEN INC11 citations85
US11285156B2Mar 29, 2022

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC16 citations85
US7759344B2Jul 20, 2010

Bis-aryl amide derivatives and methods of use

AMGEN INC15 citations84
US7687522B2Mar 30, 2010

Substituted pyridines and pyrimidines and their use in treatment of cancer

AMGEN INC8 citations83
US7101868B2Sep 5, 2006

Substituted arylamine derivatives and methods of use

AMGEN INC20 citations83
US8772480B2Jul 8, 2014

Inhibitors of PI3 kinase and/or mTOR

AMGEN INC5 citations71
US8017601B2Sep 13, 2011

Bis-aryl kinase inhibitors and method

AMGEN INC7 citations71
US12440491B2Oct 14, 2025

KRAS G12C inhibitors and methods of using the same

AMGEN INC1 citations64
US7915287B2Mar 29, 2011

Substituted heterocycles and methods of use

AMGEN INC4 citations62
US11845760B2Dec 19, 2023

PRMT5 inhibitors

AMGEN INC1 citations56
US7626030B2Dec 1, 2009

Compounds and methods of use

AMGEN INC1 citations52

ALBRECHT BRIAN K

2 patents

KIM TAE-SEONG

2 patents

CHEN GUOQING

1 patent

BO YUNXIN Y

1 patent

POTASHMAN MICHELE

1 patent